Ironwood Pharmaceuticals Inc IRWD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:52 PM EDT
6.64UNCH (UNCH)
Volume
119,045
Close
6.64quote price arrow up+0.08 (+1.22%)
Volume
1,922,814
52 week range
6.21 - 15.70
Loading...
  • Open6.55
  • Day High6.66
  • Day Low6.39
  • Prev Close6.56
  • 52 Week High15.70
  • 52 Week High Date02/14/24
  • 52 Week Low6.21
  • 52 Week Low Date05/09/24

Key Stats

  • Market Cap1.055B
  • Shares Out158.96M
  • 10 Day Average Volume3.07M
  • Dividend-
  • Dividend Yield-
  • Beta0.51
  • YTD % Change-41.96

KEY STATS

  • Open6.55
  • Day High6.66
  • Day Low6.39
  • Prev Close6.56
  • 52 Week High15.70
  • 52 Week High Date02/14/24
  • 52 Week Low6.21
  • 52 Week Low Date05/09/24
  • Market Cap1.055B
  • Shares Out158.96M
  • 10 Day Average Volume3.07M
  • Dividend-
  • Dividend Yield-
  • Beta0.51
  • YTD % Change-41.96

RATIOS/PROFITABILITY

  • EPS (TTM)-6.79
  • P/E (TTM)-0.98
  • Fwd P/E (NTM)8.95
  • EBITDA (TTM)121.498M
  • ROE (TTM)-559.14%
  • Revenue (TTM)413.551M
  • Gross Margin (TTM)27.85%
  • Net Margin (TTM)-261.50%
  • Debt To Equity (MRQ)-203.70%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ironwood Pharmaceuticals Inc

 

Profile

MORE
Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company engaged in advancing the treatment of GI diseases and redefining the standard of care for GI patients. It is engaged in the development of LINZESS (linaclotide) for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Linaclotide is also approved for the treatment of functional constipation in pediatric patients ages 6-17 years old. It is advancing...
Julie Mchugh
Independent Chairman of the Board
Thomas Mccourt
Chief Executive Officer, Director
Sravan Emany
Chief Financial Officer, Senior Vice President
Address
100 Summer Street, Suite 2300
Boston, MA
02110
United States

Top Peers

SYMBOLLASTCHG%CHG
INVA
Innoviva Inc
15.98+0.14+0.88%
COLL
Collegium Pharmaceutical Inc
33.67-0.31-0.91%
ANIP
ANI Pharmaceuticals Inc
63.77-1.05-1.62%
PROC
Procaps Group SA
2.58-0.01-0.39%
CSTL
Castle Biosciences Inc
24.22-0.14-0.57%